Skip to main content

Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent

Amphadase (formulated as a replacement for Wydase which was discontinued in 2001) contains hyaluronidase, an enzyme that breaks down hyaluronic acid in connective tissue, increasing tissue permeability. Hyaluronidase is typically used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.

Amphadase (hyaluronidase) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.